JP2012513584A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513584A5
JP2012513584A5 JP2011541583A JP2011541583A JP2012513584A5 JP 2012513584 A5 JP2012513584 A5 JP 2012513584A5 JP 2011541583 A JP2011541583 A JP 2011541583A JP 2011541583 A JP2011541583 A JP 2011541583A JP 2012513584 A5 JP2012513584 A5 JP 2012513584A5
Authority
JP
Japan
Prior art keywords
cancer
acid sequence
patient
fragment
biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011541583A
Other languages
English (en)
Japanese (ja)
Other versions
JP5947040B2 (ja
JP2012513584A (ja
Filing date
Publication date
Priority claimed from GBGB0823445.2A external-priority patent/GB0823445D0/en
Application filed filed Critical
Publication of JP2012513584A publication Critical patent/JP2012513584A/ja
Publication of JP2012513584A5 publication Critical patent/JP2012513584A5/ja
Application granted granted Critical
Publication of JP5947040B2 publication Critical patent/JP5947040B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011541583A 2008-12-23 2009-12-21 バイオマーカー Expired - Fee Related JP5947040B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0823445.2 2008-12-23
GBGB0823445.2A GB0823445D0 (en) 2008-12-23 2008-12-23 Biomarker
PCT/GB2009/002926 WO2010073001A1 (en) 2008-12-23 2009-12-21 Biomarker

Publications (3)

Publication Number Publication Date
JP2012513584A JP2012513584A (ja) 2012-06-14
JP2012513584A5 true JP2012513584A5 (https=) 2013-02-14
JP5947040B2 JP5947040B2 (ja) 2016-07-06

Family

ID=40344114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011541583A Expired - Fee Related JP5947040B2 (ja) 2008-12-23 2009-12-21 バイオマーカー

Country Status (15)

Country Link
US (1) US9624548B2 (https=)
EP (1) EP2382327B1 (https=)
JP (1) JP5947040B2 (https=)
CN (1) CN102301006B (https=)
AU (1) AU2009332712B2 (https=)
BR (1) BRPI0923525A2 (https=)
CA (1) CA2747760C (https=)
ES (1) ES2725150T3 (https=)
GB (1) GB0823445D0 (https=)
IL (1) IL213510A (https=)
MX (1) MX343251B (https=)
NZ (1) NZ593392A (https=)
RU (1) RU2573925C2 (https=)
WO (1) WO2010073001A1 (https=)
ZA (1) ZA201105184B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2472856B (en) 2009-08-21 2012-07-11 Cantargia Ab IL1-RAP modulators and uses thereof
US9403906B2 (en) * 2011-01-19 2016-08-02 Cantargia Ab Method of treatment of a solid tumor with interleukin-1 accessory protein antibody
US11371941B2 (en) * 2016-07-04 2022-06-28 Celltool Gmbh Device and method for the determination of transfection
KR101777085B1 (ko) * 2017-02-23 2017-09-11 주식회사 성균바이오텍 En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물
KR101923199B1 (ko) 2018-04-25 2018-11-28 주식회사 무진메디 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물
US20220389514A1 (en) 2019-10-02 2022-12-08 Kyushu University, National University Corporation Biomarker, method, kit and array for predicting therapeutic effects of bcg intravesical infusion therapy in treating bladder cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469089A1 (en) 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
WO2008087040A2 (en) * 2007-01-19 2008-07-24 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders
CA2708163A1 (en) 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of cell proliferative disorders

Similar Documents

Publication Publication Date Title
FI2398902T3 (fi) Menetelmiä ja koostumuksia syövän diagnoosia ja hoitoa varten
JP6630766B2 (ja) 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法
RU2485974C2 (ru) Идентификация опухолевых антигенов для диагностики и терапии
JP2008249727A5 (https=)
JP2012513584A5 (https=)
JP6941324B2 (ja) 新規な肝硬変または肝線維症のマーカー
JP2010516678A5 (https=)
WO2010017515A2 (en) Breast cancer specific markers and methods of use
JP2017181518A5 (https=)
JP2016105097A5 (https=)
JP2009544284A5 (https=)
CA2635269A1 (en) Adipogenic adenoviruses as a biomarker for disease
JP2009539082A5 (https=)
NZ595993A (en) Method for diagnosis of cancer and monitoring of cancer treatments
WO2007080597A3 (en) Polynucleotide and polypeptide sequences and methods for diagnosis
JP2008509673A5 (https=)
RU2013113314A (ru) Способы выявления антител против не4 и способы диагностики и/или прогнозирования состояний, ассоциированных с экспрессирующими не4 клетками
RU2011130795A (ru) Биомаркер
JP2007533985A5 (https=)
RU2013104137A (ru) Изоформы bard1 при раке легкого и колоректальном раке и их применение
KR102210333B1 (ko) 암의 진단용 조성물
JP2011519030A5 (https=)
EP2710143A1 (en) Method for determining whether a subject is at risk of having or developing a chronic kidney disease
JP2008547006A5 (https=)
RU2012100904A (ru) Биомаркер желудочно-кишечного рака